A comparative study of Abroma augusta mother tincture with oral hypoglycaemic drugs and patient with oral hypoglycaemic drug alone in Type 2 Diabetes mellitus

Diabetes has a significant and growing disease burden in every country, owing to the global growth in obesity and poor lifestyles. Abroma Augusta Mother tincture as add on therapy can give better results in management of Diabetes Mellitus type II, as per the Homoeopathic Literature. OBJECTIVE: Primary objective: To study if there is any significant difference in the effectiveness of management of Type 2 Diabetes Mellitus between two groups Group A: Abroma Augusta Ø along with Oral Hypoglycaemic Agents (OHA). Group B: Only OHA. Secondary objective: To evaluate the changes in the HbA1c level in Type 2 DM patients after the intervention of Abroma Augusta Ø. MATERIALS AND METHODS: 46 subjects of Type II DM were included in the study based on convenience sampling following inclusion and exclusion criteria. This was pre-test and post-test study of HbA1c of patients for 6 months, along with FBS. Intervention of Abroma Augusta Ø was made along with their regular OHA. The data was statistically analyzed using unpaired‘t’ test RESULT: Table value of t for 45 degrees of freedom is 2.02 at 5% (0.05) level of significance. Calculated value of t = 2.48 is greater than the table value at 5% level of significance. After the study we saw that Abroma Augusta Ø along with OHA was more effective in reducing the symptoms of the patient as compared to oral hypoglycaemic agents alone. CONCLUSION: According to the study, we conclude that Abroma Augusta Ø along with OHA is effective in reducing HbA1c of type 2 DM patients